Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    2.

    The relationship between combined positron emission tomography/computed tomography and clinical and light microscopic findings in choroidal melanoma.

    Faia LJ, Pulido JS, Donaldson MJ, Salomão DR, Cameron JD, Mullan B, Gunduz K.

    Retina. 2008 May;28(5):763-9.PMID: 18463523 [PubMed - indexed for MEDLINE]Related articles

    3.

    PET/CT imaging: detection of choroidal melanoma.

    Reddy S, Kurli M, Tena LB, Finger PT.

    Br J Ophthalmol. 2005 Oct;89(10):1265-9.PMID: 16170113 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.

    Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT.

    Am J Ophthalmol. 2005 Aug;140(2):193-9.PMID: 15992753 [PubMed - indexed for MEDLINE]Related articles

    5.

    Whole body PET/CT for initial staging of choroidal melanoma.

    Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC.

    Br J Ophthalmol. 2005 Oct;89(10):1270-4.PMID: 16170114 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

    Strobel K, Dummer R, Husarik DB, Pérez Lago M, Hany TF, Steinert HC.

    Radiology. 2007 Aug;244(2):566-74.PMID: 17641374 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

    Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

    Jpn J Clin Oncol. 2008 Apr;38(4):250-8.PMID: 18407934 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.

    Chin K, Finger PT, Kurli M, Tena LB, Reddy S.

    Optometry. 2007 Aug;78(8):396-401.PMID: 17662928 [PubMed - indexed for MEDLINE]Related articles

    9.

    Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.

    Miles KA, Griffiths MR, Keith CJ.

    Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):22-8. Epub 2005 Sep 23.PMID: 16180030 [PubMed - indexed for MEDLINE]Related articles

    10.

    18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.

    Hoffmann M, Vogelsang H, Kletter K, Zettinig G, Chott A, Raderer M.

    Gut. 2003 Mar;52(3):347-51.PMID: 12584214 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.

    Nakasone Y, Inoue T, Oriuchi N, Takeuchi K, Negishi A, Endo K, Mogi K.

    Ann Nucl Med. 2001 Dec;15(6):505-12.PMID: 11831398 [PubMed - indexed for MEDLINE]Related articles

    12.

    2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.

    Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR.

    Mol Imaging Biol. 2007 Jan-Feb;9(1):50-7.PMID: 17051322 [PubMed - indexed for MEDLINE]Related articles

    13.

    Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy.

    Pöttgen C, Levegrün S, Theegarten D, Marnitz S, Grehl S, Pink R, Eberhardt W, Stamatis G, Gauler T, Antoch G, Bockisch A, Stuschke M.

    Clin Cancer Res. 2006 Jan 1;12(1):97-106.PMID: 16397030 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.

    Kurli M, Chin K, Finger PT.

    Br J Ophthalmol. 2008 Apr;92(4):479-82.PMID: 18369064 [PubMed - indexed for MEDLINE]Related articles

    15.

    Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.

    Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.

    Acta Radiol. 2009 Jul;50(6):638-44.PMID: 19492198 [PubMed - indexed for MEDLINE]Related articles

    17.

    Role of FDG-PET in the assessment of survival prognosis in melanoma.

    Pleiss C, Risse JH, Biersack HJ, Bender H.

    Cancer Biother Radiopharm. 2007 Dec;22(6):740-7.PMID: 18158764 [PubMed - indexed for MEDLINE]Related articles

    18.

    Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.

    Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE.

    Dis Colon Rectum. 2000 Jun;43(6):759-67; discussion 767-70.PMID: 10859074 [PubMed - indexed for MEDLINE]Related articles

    19.

    Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.

    Freudenberg LS, Schueler AO, Beyer T, Antoch G, Kühl H, Bornfeld N, Bockisch A, Egelhof T.

    Surv Ophthalmol. 2004 Sep-Oct;49(5):537-40.PMID: 15325198 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.

    Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH.

    Skeletal Radiol. 2008 May;37(5):415-21. Epub 2008 Feb 29.PMID: 18309481 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data